Literature DB >> 19880513

Isoform-specific O-glycosylation of osteopontin and bone sialoprotein by polypeptide N-acetylgalactosaminyltransferase-1.

Hazuki E Miwa1, Thomas A Gerken, Oliver Jamison, Lawrence A Tabak.   

Abstract

Mucin-type O-glycan biosynthesis is regulated by the family of UDP-GalNAc polypeptide:N-acetylgalactosaminlytransfersases (ppGalNAcTs) that catalyzes the first step in the pathway by transferring GalNAc to Ser or Thr residues in a protein from the sugar donor UDP-GalNAc. Because not all Ser/Thr residues are glycosylated, rules must exist that signal which hydroyxamino acids acquire sugar. To date, no universal consensus signal has emerged. Therefore, strategies to deduce the subset of proteins that will be glycosylated by distinct ppGalNAcTs must be developed. Mucin-type O-glycoproteins are present abundantly in bone, where we found multiple ppGalNAcT isoforms, including ppGalNAcT-1, to be highly expressed. Thus, we compared glycoproteins expressed in wild-type and Galnt1-null mice to identify bone-associated proteins that were glycosylated in a ppGalNAcT-1-dependent manner. A reduction in the apparent molecular masses of two SIBLINGs (small integrin binding ligand N-linked glycoproteins), osteopontin (OPN) and bone sialoprotein (BSP) in the Galnt1-null mice relative to those of the wild-type was observed. Several synthetic peptides derived from OPN and BSP sequences were designed to include either known or predicted (in silico) glycosylation sites. In vitro glycosylation assays of these peptides with recombinant ppGalNAcT-1, ppGalNAcT-2, or ppGalNAcT-3 demonstrated that both SIBLINGs contained Thr/Ser residues that were preferentially glycosylated by ppGalNAcT-1. In addition, lysates prepared from wild-type, but not those from Galnt1-null derived osteoblasts, could glycosylate these peptides efficiently, suggesting that OPN and BSP contain sites that are specific for ppGalNAcT-1. Our study presents a novel and systematic approach for identification of isoform-specific substrates of the ppGalNAcT family and suggests ppGalNAcT-1 to be indispensable for O-glycosylation at specific sites of the bone glycoproteins OPN and BSP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19880513      PMCID: PMC2801249          DOI: 10.1074/jbc.M109.035436

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Cloning and expression of a novel, tissue specifically expressed member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family.

Authors:  K G Ten Hagen; F K Hagen; M M Balys; T M Beres; B Van Wuyckhuyse; L A Tabak
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

2.  cDNA cloning and expression of a novel UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase.

Authors:  F K Hagen; K G Ten Hagen; T M Beres; M M Balys; B C VanWuyckhuyse; L A Tabak
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

3.  Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption.

Authors:  H Yoshitake; S R Rittling; D T Denhardt; M Noda
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

4.  Isoform-specific O-glycosylation by murine UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-T3, in vivo.

Authors:  K Nehrke; F K Hagen; L A Tabak
Journal:  Glycobiology       Date:  1998-04       Impact factor: 4.313

5.  Determination of the site-specific O-glycosylation pattern of the porcine submaxillary mucin tandem repeat glycopeptide. Model proposed for the polypeptide:galnac transferase peptide binding site.

Authors:  T A Gerken; C L Owens; M Pasumarthy
Journal:  J Biol Chem       Date:  1997-04-11       Impact factor: 5.157

6.  Characterization of a UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase that displays glycopeptide N-acetylgalactosaminyltransferase activity.

Authors:  K G Ten Hagen; D Tetaert; F K Hagen; C Richet; T M Beres; J Gagnon; M M Balys; B VanWuyckhuyse; G S Bedi; P Degand; L A Tabak
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

7.  Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy.

Authors:  E P Bennett; H Hassan; U Mandel; M A Hollingsworth; N Akisawa; Y Ikematsu; G Merkx; A G van Kessel; S Olofsson; H Clausen
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

8.  Identification of the type I collagen-binding domain of bone sialoprotein and characterization of the mechanism of interaction.

Authors:  Coralee E Tye; Graeme K Hunter; Harvey A Goldberg
Journal:  J Biol Chem       Date:  2005-02-08       Impact factor: 5.157

9.  Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites.

Authors:  Karin Julenius; Anne Mølgaard; Ramneek Gupta; Søren Brunak
Journal:  Glycobiology       Date:  2004-09-22       Impact factor: 4.313

10.  Site-specific core 1 O-glycosylation pattern of the porcine submaxillary gland mucin tandem repeat. Evidence for the modulation of glycan length by peptide sequence.

Authors:  T A Gerken; C L Owens; M Pasumarthy
Journal:  J Biol Chem       Date:  1998-10-09       Impact factor: 5.157

View more
  18 in total

1.  Core-glycosylated mucin-like repeats from MUC1 are an apical targeting signal.

Authors:  Carol L Kinlough; Paul A Poland; Sandra J Gendler; Polly E Mattila; Di Mo; Ora A Weisz; Rebecca P Hughey
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

2.  A high-throughput O-glycopeptide discovery platform for seromic profiling.

Authors:  Ola Blixt; Emiliano Cló; Aaron S Nudelman; Kasper Kildegaard Sørensen; Thomas Clausen; Hans H Wandall; Philip O Livingston; Henrik Clausen; Knud J Jensen
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

3.  Deconstruction of O-glycosylation--GalNAc-T isoforms direct distinct subsets of the O-glycoproteome.

Authors:  Katrine T Schjoldager; Hiren J Joshi; Yun Kong; Christoffer K Goth; Sarah Louise King; Hans H Wandall; Eric P Bennett; Sergey Y Vakhrushev; Henrik Clausen
Journal:  EMBO Rep       Date:  2015-11-13       Impact factor: 8.807

4.  Probing polypeptide GalNAc-transferase isoform substrate specificities by in vitro analysis.

Authors:  Yun Kong; Hiren J Joshi; Katrine Ter-Borch Gram Schjoldager; Thomas Daugbjerg Madsen; Thomas A Gerken; Malene B Vester-Christensen; Hans H Wandall; Eric Paul Bennett; Steven B Levery; Sergey Y Vakhrushev; Henrik Clausen
Journal:  Glycobiology       Date:  2014-08-25       Impact factor: 4.313

5.  Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases.

Authors:  Thomas A Gerken; Oliver Jamison; Cynthia L Perrine; Jeremy C Collette; Helen Moinova; Lakshmeswari Ravi; Sanford D Markowitz; Wei Shen; Himatkumar Patel; Lawrence A Tabak
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

6.  Expression profile of the matricellular protein osteopontin in primary open-angle glaucoma and the normal human eye.

Authors:  Uttio Roy Chowdhury; Seung-Youn Jea; Dong-Jin Oh; Douglas J Rhee; Michael P Fautsch
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-16       Impact factor: 4.799

Review 7.  The role of mucin-type O-glycans in eukaryotic development.

Authors:  Lawrence A Tabak
Journal:  Semin Cell Dev Biol       Date:  2010-02-06       Impact factor: 7.727

8.  O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNAc-transferase-2 in regulation of concentrations of plasma lipids.

Authors:  Katrine T-B G Schjoldager; Malene B Vester-Christensen; Eric Paul Bennett; Steven B Levery; Tilo Schwientek; Wu Yin; Ola Blixt; Henrik Clausen
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

9.  Probing the contribution of individual polypeptide GalNAc-transferase isoforms to the O-glycoproteome by inducible expression in isogenic cell lines.

Authors:  John Hintze; Zilu Ye; Yoshiki Narimatsu; Thomas Daugbjerg Madsen; Hiren J Joshi; Christoffer K Goth; Adam Linstedt; Collin Bachert; Ulla Mandel; Eric P Bennett; Sergey Y Vakhrushev; Katrine T Schjoldager
Journal:  J Biol Chem       Date:  2018-10-16       Impact factor: 5.157

10.  Aerosol delivery of lentivirus-mediated O-glycosylation mutant osteopontin suppresses lung tumorigenesis in K-ras (LA1) mice.

Authors:  Arash Minai-Tehrani; Seung-Hee Chang; Jung-Taek Kwon; Soon-Kyung Hwang; Ji-Eun Kim; Ji-Young Shin; Kyeong-Nam Yu; Sung-Jin Park; Hu-Lin Jiang; Ji-Hye Kim; Seong-Ho Hong; Bitna Kang; Duyeoul Kim; Chan-Hee Chae; Kee-Ho Lee; George R Beck; Myung-Haing Cho
Journal:  Cell Oncol (Dordr)       Date:  2012-10-16       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.